Preparing Second Attempt for Previous Failed CTO PCI
Clinical and Technical Considerations for Reintervention in CTO
Selection of the Appropriate Atherectomy Device for Coronary Calcium
‘Severely calcified lesions: What is the best technique/lessons from the ECLIPSE trial.’
Rule of 6-8-12 for Left Main Upfront 2-Stenting
Prof. Jung-Min Ahn Introduces the “6-8-11 Rule” to Redefine Left Main PCI at TCTAP 2025
Temporal Decoupling Ischemic and Bleeding Risks After Complex PCI; TAILORED-CHIP Trial and Others
Future Antiplatelet Strategy to Redefine Complex PCI Care: TAILORED-CHIP Trial Will Inspire Temporal Modulation of Dual Antiplatelet Therapy
Novel Insights of Preventive PCI for Non-flow-limiting Vulnerable Plaques
Lessons From PREVENT Trial and Subgroup Analysis
Interventional Cardiology at Crossroads: A Bright Future of Collaboration; From Intervention to Prevention
Special Lecture by the 15th TCTAP Master of the Masters Award Recipient
[New RCTs from AMC] Antithrombotic Therapy for AF and CAD: EPIC-CAD Trial and More
Optimizing Antithrombotic Strategies in Patients with Atrial Fibrillation and Stable Coronary Disease
[New RCTs from AMC] Most Updated Perioperative Antiplatelet Strategy Post-PCI: ASSURE-DES and More
Perioperative Antiplatelet Strategy In Patients Who Underwent Percutaneous Coronary Intervention: From ASSURE-DES
AI in Coronary Imaging: On the Brink of Mainstream Adoption
Mainstream or a Niche Research tool?
DM and Three-Vessel Disease: Why We Need New RCTS- DEFINE-DM Trial
Can Modern PCI Rival CABG in Diabetic Multivessel CAD?
How Art and Science Work Together to Advance New Device Technology
Art and Science: A Complementary Journey of Problem-Solving
